These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 26943912)
1. DPPIV/CD26: a tumor suppressor or a marker of malignancy? Beckenkamp A; Davies S; Willig JB; Buffon A Tumour Biol; 2016 Jun; 37(6):7059-73. PubMed ID: 26943912 [TBL] [Abstract][Full Text] [Related]
2. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells. Beckenkamp A; Willig JB; Santana DB; Nascimento J; Paccez JD; Zerbini LF; Bruno AN; Pilger DA; Wink MR; Buffon A PLoS One; 2015; 10(7):e0134305. PubMed ID: 26222679 [TBL] [Abstract][Full Text] [Related]
3. Regulation and roles of CD26/DPPIV in hematopoiesis and diseases. Aliyari Serej Z; Ebrahimi Kalan A; Mehdipour A; Nozad Charoudeh H Biomed Pharmacother; 2017 Jul; 91():88-94. PubMed ID: 28448874 [TBL] [Abstract][Full Text] [Related]
4. The role of CD26/dipeptidyl peptidase IV in cancer. Havre PA; Abe M; Urasaki Y; Ohnuma K; Morimoto C; Dang NH Front Biosci; 2008 Jan; 13():1634-45. PubMed ID: 17981655 [TBL] [Abstract][Full Text] [Related]
5. CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. Carbone A; Cozzi M; Gloghini A; Pinto A Hum Pathol; 1994 Dec; 25(12):1360-5. PubMed ID: 8001932 [TBL] [Abstract][Full Text] [Related]
6. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase. Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139 [TBL] [Abstract][Full Text] [Related]
7. Expression, purification, and characterization of human dipeptidyl peptidase IV/CD26 in Sf9 insect cells. Dobers J; Zimmermann-Kordmann M; Leddermann M; Schewe T; Reutter W; Fan H Protein Expr Purif; 2002 Aug; 25(3):527-32. PubMed ID: 12182835 [TBL] [Abstract][Full Text] [Related]
8. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding. Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230 [TBL] [Abstract][Full Text] [Related]
9. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation. Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353 [TBL] [Abstract][Full Text] [Related]
10. The multifunctional or moonlighting protein CD26/DPPIV. Boonacker E; Van Noorden CJ Eur J Cell Biol; 2003 Feb; 82(2):53-73. PubMed ID: 12647932 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. Fletcher MA; Zeng XR; Maher K; Levis S; Hurwitz B; Antoni M; Broderick G; Klimas NG PLoS One; 2010 May; 5(5):e10817. PubMed ID: 20520837 [TBL] [Abstract][Full Text] [Related]
12. CD26/dipeptidyl peptidase IV and its role in cancer. Pro B; Dang NH Histol Histopathol; 2004 Oct; 19(4):1345-51. PubMed ID: 15375776 [TBL] [Abstract][Full Text] [Related]
13. Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells. Tsuji T; Sugahara K; Tsuruda K; Uemura A; Harasawa H; Hasegawa H; Hamaguchi Y; Tomonaga M; Yamada Y; Kamihira S Int J Hematol; 2004 Oct; 80(3):254-60. PubMed ID: 15540901 [TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma. Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553 [TBL] [Abstract][Full Text] [Related]
15. CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders. Thompson MA; Ohnuma K; Abe M; Morimoto C; Dang NH Mini Rev Med Chem; 2007 Mar; 7(3):253-73. PubMed ID: 17346218 [TBL] [Abstract][Full Text] [Related]
16. CD26/DPPIV down-regulation in endometrial stromal cell migration in endometriosis. Tan CW; Lee YH; Tan HH; Lau MS; Choolani M; Griffith L; Chan JK Fertil Steril; 2014 Jul; 102(1):167-177.e9. PubMed ID: 24825423 [TBL] [Abstract][Full Text] [Related]
17. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma. Fasolato S; Trevellin E; Ruvoletto M; Granzotto M; Zanus G; Boscaro E; Babetto E; Terrin L; Battocchio MA; Ciscato F; Turato C; Quarta S; Cillo U; Pontisso P; Vettor R Life Sci; 2018 May; 200():134-141. PubMed ID: 29524519 [TBL] [Abstract][Full Text] [Related]
18. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Tanaka T; Kameoka J; Yaron A; Schlossman SF; Morimoto C Proc Natl Acad Sci U S A; 1993 May; 90(10):4586-90. PubMed ID: 7685106 [TBL] [Abstract][Full Text] [Related]
19. Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway. Tan EY; Richard CL; Zhang H; Hoskin DW; Blay J Am J Physiol Cell Physiol; 2006 Sep; 291(3):C433-44. PubMed ID: 16611738 [TBL] [Abstract][Full Text] [Related]
20. The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells. Lefort EC; Blay J Clin Exp Metastasis; 2011 Apr; 28(4):337-49. PubMed ID: 21298326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]